Categories
Health

3D Printed Medical Device Market Size Will Hit USD 3,510 Million by 2026

The global 3D Printed Medical Device Market in 2019 was approximately USD 1,130 million. The market is expected to grow at a CAGR of 17.8% and is anticipated to reach around USD 3,510 million by 2026.

3D printing is the process of manufacturing a three-dimensional solid object from a digital file. This object is created by successive adding of layers of material till the object is created. Therefore this process is also called additive manufacturing. In recent years, 3D printing has developed significantly and can now perform crucial roles in many applications, with the most important being manufacturing, medicine, architecture, custom art, and design.

Sample Report is available HERE

The 3D Printed Medical Device market is segmented based on, technology, type, and region. On the basis of technology segmentation, the market is classified into Electron Beam Melting (EBM) Technology, Laser Beam Melting (LBM) Technology, Direct Metal Laser Sintering (DMLS), Digital Light Processing, Photo polymerization. In terms of type segmentation, the market is bifurcated into Surgical Guides, Dental Guides, Orthopedic Guides, Surgical Instruments, Scalpels, Prosthetics and Implants, Tissue Engineering Products.

The 3D Printed Medical Device market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire 3D Printed Medical Device market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

Know more before buying this report HERE

Top Market Players

Some of the leading and top companies in the 3D printing medical devices market contain Advanced Solutions Life Sciences, Aspect Biosystem, Cyfuse Biomedical K.K., Envisiontec, and Nano Dimension.

Categories
Health

Nanocellulose Market Set to Grow USD 670 Million by 2026

According to the report, The global Nanocellulose market in 2019 was approximately USD 290 Million. The market is expected to grow above a CAGR of 19% and is anticipated to reach over USD 670 Million by 2026.

Nanocellulose is a substance made up of micro-sized cellulose oligomers with a high ratio of length to width (appearance) Typical measurements vary from 5-20 nm to extreme micrometers. In nature it is semi-plastic and under normal conditions has the properties of a gel and viscous liquid, but when it is agitated, it becomes less viscous and can float. This property is referred to as thixotropy.

Get Sample Research Report HERE

Nanocellulose is expected to replace a number of products in the future in order to generate reproducible and reliable data for the marketing of nanocellulose products and the acquisition of consumer confidence. Nanocellulose manufacturers and research institutions are expected to play a key role in addressing the trust issues associated with the launch of new nanocellulose products. Appropriate promotional practices and product positioning will lead consumers to adopt nanocellulose products. Government financing, along with an efficient supply chain, would also play an important role in increasing global market penetration.

The Nanocellulose market is segmented based on drug type, application and region. On the basis of drug type segmentation, the market is classified into Microfibrillated Cellulose and Cellulose Nanocrystals. Based on application, the market is bifurcated into Pulp& paper, Composites & packaging, Biomedical & pharmaceuticals, and Electronics & sensors.

Browse detail report with in-depth TOC HERE

Some of the essential players operating in the Nanocellulose market, but not restricted to include Sappi Ltd.Innventia ABBorregard ASAFpinnovationsCelluForce IncAmerican Process IncSTORA ENSODaicel FineChem LtdKruger IncNippon Paper Group IncCelluComp Ltd.J. Rettenmaire & Sohne GmBH (JRS)Melodea LtdAsahi Kasei Corporation, and Others.

Contact Us:

Facts & Factors

USA: 1 (347) 690-0211

Email: [email protected]

Web: https://www.fnfresearch.com

Categories
Health

Microbiome Therapeutics Market to Surge to USD 838.2 Million by 2026

According to the report, The global microbiome therapeutics market in 2019 was approximately USD 34.1 Million. The market is expected to grow above a CAGR of 58 % and is anticipated to reach over USD 838.2 Million by 2026.

The microbiome is a genetic material of all the microbes that resides within the body. The microbes contain 200 times the number of genes as compared to human genome. The microbiome consists of thousands of different bacterial species mainly in the mouth, vagina and the mouth. The gut microbiome is an important element that assist in controlling digestion and improving immunity system. The balance of microbes is very important as it may result in weight gain, high cholesterol, high blood sugar and other disorders.

Request Free Sample copy of Research Report HERE

The microbiome therapeutics market research report delivers an acute valuation and taxonomy of the microbiome therapeutics industry by practically splitting the market based on product type, application, distribution channel and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the microbiome therapeutics industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the microbiome therapeutics industry is provided for the leading economies of the world.

The microbiome therapeutics market is segmented based on product type, application, distribution channel and region. On the basis of product type segmentation, the market is classified into prebiotics, probiotics, and synbiotics. On the basis of the distribution channel, the market is categorized into drug stores, super and hypermarkets, hospital pharmacies, and e-commerce stores. On the basis of the application area, the market is divided into C. difficile, Crohn’s Disease, Inflammatory Bowel Disease [IBD], Diabetes.

Request a customized copy of the report HERE

Some of the essential players operating in the microbiome therapeutics market, but not restricted to include Yakult, AbbVie Inc., Pfizer Inc., AB-Biotics, Ganeden, Vedanta Biosciences, Johnson and Johnson, Dannon, Sigma-Tau Pharmaceuticals, Bayer, and Others.

Contact Us:

Facts & Factors

USA: 1 (347) 690-0211

Email: [email protected]

Web: https://www.fnfresearch.com

Categories
Health

Intravenous Iron Drugs Market to Top USD 3,000 Million by 2026

According to the report, The global intravenous iron drugs market in 2019 was approximately USD 1,800 Million. The market is expected to grow above a CAGR of 8.0% and is anticipated to reach over USD 3,000 Million by 2026.

Intravenous iron drugs and oral iron supplementation are considered as primary therapies for iron deficiency. Moreover, efficacy of intravenous iron drugs and oral iron supplementation has played a key role in the adoption of iron supplement drugs. IV iron drugs are often preferred over oral iron supplementation because of high gastrointestinal AE rate of oral iron supplements. A long treatment of oral iron supplements is needed to cure anemia. IV iron drugs are directly absorbed in the blood which results in the faster increase of Hb level in the body. IV iron drugs is safe and is increasingly adopted by physicians and other medical professionals.

Get Sample Research Report HERE

The intravenous iron drugs market research report delivers an acute valuation and taxonomy of the intravenous iron drugs industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the intravenous iron drugs industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the intravenous iron drugs industry is provided for the leading economies of the world.

The intravenous iron drugs market is segmented based on product, application, and region. On the basis of product, the market is classified into iron dextran, iron sucrose, ferric carboxymaltose, and others. On the basis of application, the market is classified into chronic kidney disease, inflammatory bowel disease, cancer, and others.

Browse detail report with in-depth TOC HERE

Some of the essential players operating in the intravenous iron drugs market, but not restricted to include Allergan Inc., Daiichi Sankyo Company Ltd., Rockwell Medical Technologies Inc., AMAG Pharmaceuticals Inc., Sanofi, Fresenius Medical Care AG & Co., Vifor Pharma Management Ltd., Pharmacosmos A/S, Shield Therapeutics Plc, American Regent Inc., and others.

Contact Us:

Facts & Factors

USA: 1 (347) 690-0211

Email: [email protected]

Web: https://www.fnfresearch.com